Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis

• Published in: Arthritis care & research (2010) Vol. 64; no. 12; pp. 1864 - 1870
• Main Authors: Richards, J. Steuart, Cannon, Grant W., Hayden, Candace L., Amdur, Richard L., Lazaro, Deana, Mikuls, Ted R., Reimold, Andreas M., Caplan, Liron, Johnson, Dannette S., Schwab, Pascale, Cherascu, Bogdan N., Kerr, Gail S.
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.12.2012; Wiley-Blackwell
• Subjects: Absorptiometry, Photon; Age Factors; Aged; Arthritis, Rheumatoid - drug therapy; Arthritis, Rheumatoid - ethnology; Biological and medical sciences; Bones, joints and connective tissue. Antiinflammatory agents; Cohort Studies; Diphosphonates - therapeutic use; Diseases of the osteoarticular system; Drug Utilization - statistics & numerical data; Female; Humans; Inflammatory joint diseases; Longitudinal Studies; Male; Medical sciences; Medication Adherence - ethnology; Medication Adherence - statistics & numerical data; Middle Aged; Pharmacology. Drug treatments; Registries; Time Factors; Veterans - statistics & numerical data; Veterans Health - statistics & numerical data; Immunopathology; Chronic; Antiosteoporotic; Treatment; Antiosteoclastic agent; Rheumatoid arthritis; Diseases of the osteoarticular system; Rheumatology; Autoimmune disease; Inflammatory joint disease; Veteran; Bisphosphonates

Objective Pharmacy Benefits Management program data for patients enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry were linked with clinical data to determine bisphosphonate adherence and persistence among US veterans with rheumatoid arthritis (RA) and to determine factors associ...